CAL
LJPC

Capital Advisors Ltd’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Capital Advisors Ltd’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,000
Closed -$24K – 420
2016
Q3 		$24K Buy
+1,000
New +$18.8K 0.01% 244

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Advisors Ltd's LJPC Position: Q4 2016 in Review

Capital Advisors Ltd sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2016, closing a stake of 1,000 shares — an estimated $24K sold.

Capital Advisors Ltd first reported a position in LJPC in Q3 2016 and held it in 1 quarter. The position peaked at $24K in Q3 2016. 62 funds tracked by Wall St. Rank hold LJPC as of Q4 2016.

  • Capital Advisors Ltd reported no remaining La Jolla Pharmaceutical Company position as of Q4 2016 after selling out during the quarter.
  • Capital Advisors Ltd sold 1,000 La Jolla Pharmaceutical Company shares in Q4 2016, an estimated $24K.
  • Capital Advisors Ltd first reported a position in La Jolla Pharmaceutical Company in Q3 2016 and held it in 1 quarter.
  • Capital Advisors Ltd's La Jolla Pharmaceutical Company position peaked at $24K in Q3 2016.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2016.

Based on Capital Advisors Ltd's 13F filing for Q4 2016, filed 20 Jan 2017.